Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Race agnostic models maintain accuracy in predicting m-protein levels in multiple myeloma

Rahul Thakur, James Driscoll, Jennifer Ahlstrom, Jay Hydren, Mason Barnes, Juan Pablo Capdevila, Brian Betts, Marco Davila, Shernan Holtan, Jorge Arturo Hurtado Martinez, Ehsan Malek

Blood (2025) 146 (Supplement 1): 2810.

https://doi.org/10.1182/blood-2025-2810

Published: 2025

Journal Articles

Unstructured serum electrophoresis data limits real world AI models in multiple myeloma: Evaluation of 384 institutions across United States

Ehsan Malek, Juan Pablo Capdevila, Rahul Thakur, Mason Barnes, Jay Hydren, Jennifer Ahlstrom, James Driscoll, Marco Davila, Shernan Holtan, Brian Betts, Karla Mariana Castro Bórquez, Jorge Arturo Hurtado Martinez

Blood (2025) 146 (Supplement 1): 2809.

https://doi.org/10.1182/blood-2025-2809

Published: 2025

Journal Articles

Accelerated immune aging after induction therapy in multiple myeloma revealed by donor-referenced immune age modeling

Ehsan Malek, Megan Herr, James Driscoll, Paul Wallace, Marco Davila, Brian Betts, Shernan Holtan, Hamza Hassan, Theresa Hahn, Han Yu

Blood (2025) 146 (Supplement 1): 3935.

https://doi.org/10.1182/blood-2025-3935

Published: 2025

Journal Articles

CD83 CAR T overcome CD19 antigen loss in B cell malignancies after CD19-directed therapy

Brian Betts, Constanza Savid-Frontera, Shannon McSain, Kelly Walton, Nolan Beatty, Payal Goala, Shernan Holtan, Meredith Stone, Frederick Locke, Anne Eaton, Michael Linden, Renier Brentjens, Marco Davila

Blood (2025) 146 (Supplement 1): 4098.

https://doi.org/10.1182/blood-2025-4098

Published: 2025

Journal Articles

Should Transplant Centers Prioritize Further Stem Cell Collection for Future CAR T-Cell Therapy Boosts? an Economic and Clinical Assessment

Ehsan Malek, Marco Davila, Hector Tirado, Shernan G. Holtan, Brian Betts, Han Yu

Blood (2024) 144 (Supplement 1): 7252.

https://doi.org/10.1182/blood-2024-200893

Published: 2024

Journal Articles

Influence of Myeloma Cell Expressed CD28 and CD86 on BCMA CAR T Cell Efficacy and Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS)

Ehsan Malek, Kimberly Crasti, Grant Schofield, Shernan G. Holtan, Megan M Herr, Marco Davila, You-Wen Qian, Brian Betts, Mackenzie Lieberman, Jason Tong, Colin Chavel, Kelvin P. Lee, Scott Olejniczak

Blood (2024) 144 (Supplement 1): 3445.

https://doi.org/10.1182/blood-2024-198255

Published: 2024

Journal Articles

Phase I Study of FT538 + Daratumumab for Treatment of r/r AML

Joseph E. Maakaron, Cassie Seichter, Rose Wangen, Andrea Hoeschen, Deepa Kolaseri Krishnadas, Kateryna Kent, Ryan Shanley, Daniel O'Leary, Najla H El Jurdi, Shernan G. Holtan, Brian Betts, Mark Juckett, Jeffrey S Miller

Blood (2023) 142 (Supplement 1): 4842.

https://doi.org/10.1182/blood-2023-189132

Published: 2023

Journal Articles

Aurora Kinase a Inhibition for Gvhd and Relapse Prevention after Allogeneic HCT: Phase I Trial in Combination with Ptcy/Sirolimus

Shernan G. Holtan, Kelly Walton, Najla H El Jurdi, Joseph E. Maakaron, Mark Juckett, Veronika Bachanova, Thomas Myers, Linda J. Paradiso, Todd DeFor, Qing Cao, Brian Betts

Blood (2023) 142 (Supplement 1): 4925.

https://doi.org/10.1182/blood-2023-181292

Published: 2023

Journal Articles

Simvastatin with Intrathecal Dexamethasone Reduces Neurotoxicity in Adults Receiving Chimeric Antigen Receptor (CAR) T-Cells Treatment

Nuttavut Sumransub, Cassie Seichter, Kateryna Kent, Ryan Shanley, Marie Hu, Daniel O'Leary, Najla H El Jurdi, Shernan G. Holtan, Brian Betts, Mark Juckett, Jeremy R. Allred, Veronika Bachanova, Jeffrey S Miller, Joseph E. Maakaron

Blood (2023) 142 (Supplement 1): 3493.

https://doi.org/10.1182/blood-2023-187070

Published: 2023

Journal Articles

Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease

Anandharaman Veerapathran, Joseph Pidala, Francisca Beato, Brian Betts, Jongphil Kim, Joel G. Turner, Marc K. Hellerstein, Xue-Zhong Yu, William Janssen, Claudio Anasetti

Blood (2013) 122 (13): 2251–2261.

https://doi.org/10.1182/blood-2013-03-492397

Published: 2013

Includes: Supplemental data

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Race agnostic models maintain accuracy in predicting m-protein levels in multiple myeloma

Unstructured serum electrophoresis data limits real world AI models in multiple myeloma: Evaluation of 384 institutions across United States

Accelerated immune aging after induction therapy in multiple myeloma revealed by donor-referenced immune age modeling

CD83 CAR T overcome CD19 antigen loss in B cell malignancies after CD19-directed therapy

Should Transplant Centers Prioritize Further Stem Cell Collection for Future CAR T-Cell Therapy Boosts? an Economic and Clinical Assessment

Influence of Myeloma Cell Expressed CD28 and CD86 on BCMA CAR T Cell Efficacy and Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS)

Phase I Study of FT538 + Daratumumab for Treatment of r/r AML

Aurora Kinase a Inhibition for Gvhd and Relapse Prevention after Allogeneic HCT: Phase I Trial in Combination with Ptcy/Sirolimus

Simvastatin with Intrathecal Dexamethasone Reduces Neurotoxicity in Adults Receiving Chimeric Antigen Receptor (CAR) T-Cells Treatment

Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only